Deep-pocketed investors have adopted a bearish approach towards Biogen (NASDAQ:BIIB), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BIIB usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Biogen. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 2 are puts, totaling $156,230, and 7 are calls, amounting to $269,720.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $220.0 to $260.0 for Biogen during the past quarter.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Biogen's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Biogen's substantial trades, within a strike price spectrum from $220.0 to $260.0 over the preceding 30 days.
Biogen Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
About Biogen
Current Position of Biogen
- With a trading volume of 479,866, the price of BIIB is up by 0.08%, reaching $221.91.
- Current RSI values indicate that the stock is may be oversold.
- Next earnings report is scheduled for 54 days from now.
What The Experts Say On Biogen
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $286.4.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Biogen options trades with real-time alerts from Benzinga Pro.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
